Thus, the identification of phytocomponents, or bioactive molecules, from plants provides a framework and an opportunity for the development of pancreatic lipase inhibitors that could eventually be developed into anti-obesity drugs [7]. The gene discussed is PNLIP; the disease is obesity due to melanocortin 4 receptor deficiency.